Showing results (421-430 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|October 7, 2021
Treatment-Free Remission: the New Goal in CML TherapyEhab Atallah, Kendra SweetCurrent Hematologic Malignancy Reports|June 23, 2019
Pathogen-Specific T Cells Beyond CMV, EBV and AdenovirusWei Jiang, Barbara Withers, Gaurav Sutrave, et al.Current Hematologic Malignancy Reports|June 28, 2019
Induced Pluripotent Stem Cell (iPSC)-Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and ChallengesAlexandros Nianias, Maria ThemeliCurrent Hematologic Malignancy Reports|June 15, 2019
Is There a Role for Dose Modification of TKI Therapy in CML?M CoplandCurrent Hematologic Malignancy Reports|October 18, 2021
The Evolving Landscape of Frontline Therapy in Chronic Phase Chronic Myeloid Leukemia (CML)Heather R Wolfe, Lindsay A M ReinCurrent Hematologic Malignancy Reports|September 29, 2021
Elevating Twitter-Based Journal Club Discussions by Leveraging a Voice-Based Platform: #HemepathJC Meets ClubhouseAadil Ahmed, Kamran M Mirza, Sanam LoghaviCurrent Hematologic Malignancy Reports|October 14, 2021
Future Directions in Chronic Phase CML TreatmentNathalie Javidi-Sharifi, Gabriela HobbsCurrent Hematologic Malignancy Reports|July 7, 2019
Overcoming Challenges in Process Development of Cellular TherapiesSteven L Highfill, David F StroncekCurrent Hematologic Malignancy Reports|May 12, 2019
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple MyelomaM Offidani, M Boccadoro, F Di Raimondo, et al.Current Hematologic Malignancy Reports|June 30, 2019
Towards Automated Manufacturing for Cell TherapiesDavid Smith, Thomas R J Heathman, Alex Klarer, et al.Pageof 86